<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">M. Bruysters</style></author><author><style face="normal" font="default" size="100%">L. Tesolin</style></author><author><style face="normal" font="default" size="100%">J. Lange</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Phase 2 testing: where are we now?</style></title><secondary-title><style face="normal" font="default" size="100%">OMCL Annual Meeting EDQM 2023</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">bulk</style></keyword><keyword><style  face="normal" font="default" size="100%">phase 2</style></keyword><keyword><style  face="normal" font="default" size="100%">vaccines</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">06/2023</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">EDQM</style></publisher><pub-location><style face="normal" font="default" size="100%">Madrid, SPain</style></pub-location><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>